Generic medicines could save Europe €60 billion, says IMS Health
This article was originally published in Scrip
Executive Summary
For countries to receive the full benefit from generic medicines, greater emphasis must be placed on increasing volume use rather than focusing simply on price, says a new report from IMS Health which gives a glowing review of the benefits of the EU generics sector.